In Vitro Diagnostics Market to Witness Promising Growth Opportunities by 2024-2035
The global in vitro diagnostics (IVD) market is projected to grow from USD 108 billion in 2024 to USD 190 billion by 2035, reflecting a steady CAGR of 5.2%. Rising demand for point-of-care testing, molecular diagnostics, and advanced immunoassays are among the key factors fueling the expansion of the in vitro diagnostic industry.
Roots Analysis’ latest report, "In Vitro Diagnostics Market," takes an in-depth look at industry evolution. It tracks historical performance, evaluates regional market dynamics, and offers comprehensive projections up to 2035.
The study highlights major market growth drivers, emerging business opportunities, and transformative innovations. It also delves into the competitive landscape, profiling top companies’ market shares, technology portfolios, product strategies, and expansion initiatives.
Further, the report reviews partnerships, acquisitions, and R&D collaborations that are enabling companies to strengthen their market presence and shape the future of the in vitro diagnostic industry.
Competitive Landscape
Leading players include Abbott Laboratories, Agilent, Becton Dickinson, bioMérieux, Bio-Rad, Danaher Corporation, DiaSorin, Exact Sciences, Fujifilm, Gold Standard Diagnostics, Grifols, Hologic, Illumina, LabCorp, Qiagen, Quest Diagnostics, QuidelOrtho, Roche, Siemens Healthineers, Sysmex, Thermo Fisher Scientific, and Werfen.
Market Segmentation
The in vitro diagnostics market has been segmented across several key parameters to offer a detailed understanding of the industry landscape. By test type, the market includes laboratory testing and point-of-care (POC) testing, reflecting the shift toward both centralized and decentralized healthcare solutions. In terms of offering, the market covers reagents, instruments, and services, each playing a vital role in enabling accurate and timely diagnostic outcomes.
When classified by technology, the market addresses major categories such as clinical chemistry, hematology, immunoassay, molecular diagnostics, and other emerging diagnostic techniques. Across therapeutic areas, the in vitro diagnostic industry supports applications in autoimmune diseases, cardiovascular disorders, diabetes, infectious diseases, renal disorders, oncological disorders, and several other health conditions.
End users of IVD solutions primarily include hospitals, laboratories, and other healthcare facilities. Geographically, the market has been analyzed across key regions, namely North America (US, Canada), Europe (including countries such as the UK, Germany, France, Italy, Spain, and others), Asia (China, India, Japan, South Korea, and others), Latin America (Brazil, Mexico, Argentina), the Middle East and North Africa (Egypt, Israel, Saudi Arabia), and the Rest of the World, showcasing the expanding global footprint of the in vitro diagnostic industry.
Research Methodology
Our research methodology involved a mix of primary interviews, secondary desk research, and expert consultations. By combining qualitative insights with quantitative analysis, we captured real-world perspectives and emerging trends shaping the IVD market’s future.
We appreciate your interest in our research. For more information or to request a customized edition, please get in touch. We are committed to delivering insights tailored to meet your business goals.
Get More:
https://www.rootsanalysis.com/reports/in-vitro-diagnostics-market.htmlIn Vitro Diagnostics Market to Witness Promising Growth Opportunities by 2024-2035
The global in vitro diagnostics (IVD) market is projected to grow from USD 108 billion in 2024 to USD 190 billion by 2035, reflecting a steady CAGR of 5.2%. Rising demand for point-of-care testing, molecular diagnostics, and advanced immunoassays are among the key factors fueling the expansion of the in vitro diagnostic industry.
Roots Analysis’ latest report, "In Vitro Diagnostics Market," takes an in-depth look at industry evolution. It tracks historical performance, evaluates regional market dynamics, and offers comprehensive projections up to 2035.
The study highlights major market growth drivers, emerging business opportunities, and transformative innovations. It also delves into the competitive landscape, profiling top companies’ market shares, technology portfolios, product strategies, and expansion initiatives.
Further, the report reviews partnerships, acquisitions, and R&D collaborations that are enabling companies to strengthen their market presence and shape the future of the in vitro diagnostic industry.
Competitive Landscape
Leading players include Abbott Laboratories, Agilent, Becton Dickinson, bioMérieux, Bio-Rad, Danaher Corporation, DiaSorin, Exact Sciences, Fujifilm, Gold Standard Diagnostics, Grifols, Hologic, Illumina, LabCorp, Qiagen, Quest Diagnostics, QuidelOrtho, Roche, Siemens Healthineers, Sysmex, Thermo Fisher Scientific, and Werfen.
Market Segmentation
The in vitro diagnostics market has been segmented across several key parameters to offer a detailed understanding of the industry landscape. By test type, the market includes laboratory testing and point-of-care (POC) testing, reflecting the shift toward both centralized and decentralized healthcare solutions. In terms of offering, the market covers reagents, instruments, and services, each playing a vital role in enabling accurate and timely diagnostic outcomes.
When classified by technology, the market addresses major categories such as clinical chemistry, hematology, immunoassay, molecular diagnostics, and other emerging diagnostic techniques. Across therapeutic areas, the in vitro diagnostic industry supports applications in autoimmune diseases, cardiovascular disorders, diabetes, infectious diseases, renal disorders, oncological disorders, and several other health conditions.
End users of IVD solutions primarily include hospitals, laboratories, and other healthcare facilities. Geographically, the market has been analyzed across key regions, namely North America (US, Canada), Europe (including countries such as the UK, Germany, France, Italy, Spain, and others), Asia (China, India, Japan, South Korea, and others), Latin America (Brazil, Mexico, Argentina), the Middle East and North Africa (Egypt, Israel, Saudi Arabia), and the Rest of the World, showcasing the expanding global footprint of the in vitro diagnostic industry.
Research Methodology
Our research methodology involved a mix of primary interviews, secondary desk research, and expert consultations. By combining qualitative insights with quantitative analysis, we captured real-world perspectives and emerging trends shaping the IVD market’s future.
We appreciate your interest in our research. For more information or to request a customized edition, please get in touch. We are committed to delivering insights tailored to meet your business goals.
Get More: https://www.rootsanalysis.com/reports/in-vitro-diagnostics-market.html
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Urdu
Portuguese (Brazil)
Greek